L233-1326 Screening compound: 8-({5-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)-1,4-dioxa-8-azaspiro[4.5]decane

L233-1326 Screening compound: 8-({5-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)-1,4-dioxa-8-azaspiro[4.5]decane
L233-1326 Screening compound: 8-({5-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)-1,4-dioxa-8-azaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound L233-1326
8-({5-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)-1,4-dioxa-8-azaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L233-1326

Molecular Formula

C20H20ClN3O5S2 (C20 H20 ClN3 O5 S2)

Compound Name

8-({5-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)-1,4-dioxa-8-azaspiro[4.5]decane

IUPAC name

8-({5-[3-(3-chlorophenyl)-124-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)-14-dioxa-8-azaspiro[4.5]decane

SMILES

Cc(sc(-c1nc(-c2cccc(Cl)c2)no1)c1)c1S(N(CC1)CCC11OCCO1)(=O)=O

InChI

InChI=1S/C20H20ClN3O5S2/c1-13-17(31(25,26)24-7-5-20(6-8-24)27-9-10-28-20)12-16(30-13)19-22-18(23-29-19)14-3-2-4-15(21)11-14/h2-4,11-12H,5-10H2,1H3

InChI Key

CNFDTFLOABBYGI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27237383

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.98

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.651

Distribution Coefficient, logD

4.651

Water Solubility, LogSw

-4.77

Polar Surface Area

78.810

Acid Dissociation Constant (pKa)

27.46

Base Dissociation Constant (pKb)

-5.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

L233-1326 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L233-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L233-1326?
Check Price and Availability of L233-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L233-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L233-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L233-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L233-1326 available by request